ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,800,000 | -38.5% | 182,686 | -3.2% | 0.00% | -50.0% |
| Q3 2016 | $6,183,000 | +32.4% | 188,670 | +0.9% | 0.01% | +33.3% |
| Q2 2016 | $4,671,000 | +104.9% | 187,060 | +101.0% | 0.01% | +100.0% |
| Q1 2016 | $2,280,000 | -37.2% | 93,080 | -15.2% | 0.00% | -40.0% |
| Q4 2015 | $3,628,000 | +1.8% | 109,825 | +0.9% | 0.01% | 0.0% |
| Q3 2015 | $3,565,000 | -37.3% | 108,817 | +1.4% | 0.01% | -28.6% |
| Q2 2015 | $5,684,000 | +203.6% | 107,298 | +65.4% | 0.01% | +250.0% |
| Q1 2015 | $1,872,000 | +60.1% | 64,857 | +61.4% | 0.00% | 0.0% |
| Q4 2014 | $1,169,000 | +132.4% | 40,180 | +1.2% | 0.00% | +100.0% |
| Q3 2014 | $503,000 | -36.6% | 39,700 | +0.3% | 0.00% | 0.0% |
| Q2 2014 | $794,000 | – | 39,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |